Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bone Biologics Corp - Common Stock (NQ:BBLG)

0.5010 -0.0366 (-6.81%)
Streaming Delayed Price Updated: 1:39 PM EDT, Sep 17, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Bone Biologics Corp - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
These stocks are moving in today's pre-market session ↗
Via Chartmill
News headline image
Bone Biologics Expands Trial Sites
Addition of three sites strengthens expectation to complete enrollment by year-end 2026 
From BONE BIOLOGICS CORPORATION
Via GlobeNewswire
News headline image
Bone Biologics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
From BONE BIOLOGICS CORPORATION
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
Gainers Bone Biologics (NASDAQ:BBLG) stock moved upwards by 17.7% to $1.07 during Wednesday's pre-market session. The market value of their outstanding shares is at $1.6 million. Definium Therapeutics 
Via Benzinga
News headline image
Bone Biologics Achieves 32-Month Validated Shelf Life for rhNELL-1
Milestone strengthens manufacturing flexibility and supports pivotal study readiness 
From BONE BIOLOGICS CORPORATION
Via GlobeNewswire
News headline image
Bone Biologics Issues Mid-Year Shareholder Update Highlighting Progress Across 2026 Priorities
Strengthened capital position supports continued advancement of NB1 clinical development, manufacturing readiness and intellectual property initiatives through Q2 2027 
From BONE BIOLOGICS CORPORATION
Via GlobeNewswire
News headline image
Bone Biologics Announces up to $9.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules
$3.0 million upfront with up to approximately $6.0 million of potential additional gross proceeds upon the exercise in full of warrants in cash 
From BONE BIOLOGICS CORPORATION
Via GlobeNewswire
News headline image
Why Marvell Technology Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket ↗
href=https://www.benzinga.com/quote/RMSG target=_blank>(NASDAQ: RMSG) lost 67.6% to $0.69 in pre-market trading. The company recently announced a 1-for-20 reverse stock split.The shares of Marvell... 
Via Benzinga
Topics Stocks
News headline image
Bone Biologics Achieves 29-Month Validated Shelf Life for rhNELL-1
Milestone advances commercial and manufacturing readiness ahead of anticipated pivotal study scale-up 
From BONE BIOLOGICS CORPORATION
Via GlobeNewswire
News headline image
Bone Biologics Highlights 2025 Key Operational, Scientific, and Corporate Milestones and Provides 2026 Outlook
Key accomplishments include expanded rhNELL-1 shelf life, advanced NB1 development, strengthened balance sheet, and maintained Nasdaq compliance 
From BONE BIOLOGICS CORPORATION
Via GlobeNewswire
News headline image
Bone Biologics Improves Extension of rhNELL-1 Product Shelf Life to 24 Months
Milestone advances manufacturing readiness and supports long-term commercialization strategy 
From BONE BIOLOGICS CORPORATION
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
 
Via Benzinga
News headline image
Let's take a look at the stocks that are in motion in today's session. ↗
Curious about what's happening in today's session? Check out the latest stock movements and price changes. 
Via Chartmill
News headline image
Discover the most active stocks in Thursday's session. ↗
Curious about the most active stocks in today's session? Get a glimpse into the stocks that are generating the highest trading volume and capturing market attention. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
 
Via Benzinga
News headline image
Top stock movements in today's session. ↗
Keep an eye on the top gainers and losers in Thursday's session, as they reflect the most notable price movements. 
Via Chartmill
News headline image
Which stocks are gapping on Thursday? ↗
Traders are paying attention to the gapping stocks in Thursday's session. Let's dive into which stocks are experiencing notable gaps. 
Via Chartmill
News headline image
Top movers in Thursday's pre-market session ↗
As we await the opening of the US market on Thursday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Bone Biologics CEO Issues Letter to Stockholders Highlighting Company Update and Outlook
From Bone Biologics Corporation
Via Business Wire
News headline image
Bone Biologics to Participate in the H.C. Wainwright Global Investment Conference
From Bone Biologics Corporation
Via Business Wire
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Bone Biologics Announces Closing of $5.0 Million Public Offering
From Bone Biologics Corporation
Via Business Wire
News headline image
Why Venus Concept Shares Are Trading Higher By Over 32%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
Get insights into the top gainers and losers of Friday's after-hours session. ↗
Discover the top movers in Friday's after-hours session and stay informed about the post-market dynamics. 
Via Chartmill
News headline image
Peraso (NASDAQ: PRSO) Pushes Back on Mobix Labs (NASDAQ: MOBX) Takeover Bid, Valuation, Nasdaq Compliance Etc. – More Stocks Inside
Via AB Newswire
Topics Regulatory Compliance
News headline image
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Friday. Let's explore the market movements and identify the stocks with significant gaps. 
Via Chartmill
News headline image
Why Is Bone Biologics Stock Surging On Friday? ↗
Bone Biologics filed a USPTO patent for NELL-1 and announced a $5 million offering to support trials and expand its bone regeneration patent portfolio. 
Via Benzinga
Topics Intellectual Property
News headline image
Bone Biologics Announces Pricing of $5.0 Million Public Offering
From Bone Biologics Corporation
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.